MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,611K
EPS
-$0.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
-
-
0
-
Research and development
1,101
4,912
5,035
2,311
General and administrative
3,479
2,034
2,333
1,744
Other operating income
1,405
-
-
-
Total operating expenses
3,175
6,946
7,368
4,055
Loss from operations
-3,175
-6,946
-7,368
-4,055
Change in fair value of warrant liability
-215
159
89
3
Other (loss) income, net
-94
-2
14
96
Net (gain) income
-3,054
-7,107
-7,443
-3,962
Net (gain) income attributable to common stockholders, basic
-2,611
-5,692
-4,558
-3,035
Basic EPS
-0.16
-0.53
-0.554
-0.34
Diluted EPS
-0.16
-0.53
-0.544
-0.34
Basic Average Shares
15,864,041
10,640,625
8,228,169*
8,818,859
Diluted Average Shares
15,864,041
10,640,625
8,376,380*
8,818,859
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (gain) income
attributable to common...
-$2,611K
(-317.76%↓ Y/Y)
something is missing
$443K
Net (gain) income
-$3,054K
(-233.77%↓ Y/Y)
Change in fair value of
warrant liability
-$215K
(-47.26%↓ Y/Y)
Loss from operations
-$3,175K
(-154.20%↓ Y/Y)
Other (loss) income,
net
-$94K
(-150.00%↓ Y/Y)
Total operating
expenses
$3,175K
(-20.27%↓ Y/Y)
Other operating
income
$1,405K
General and
administrative
$3,479K
(105.74%↑ Y/Y)
Research and development
$1,101K
(-51.94%↓ Y/Y)
Buy us a coffee
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW)